EY Polska advised on the sale of shares of MED-LUX, specialist medical centers, to Scanmed

The strategy and transaction advisory team of EY supported the owners of MED-LUX Sp. z o.o. in the acquisition of an investor for the Company's two specialized medical clinics in Przeźmierowo and Luboń located near Poznań. The owners of MED-LUX signed a sales agreement with Scanmed S.A., a portfolio company of the Abris Capital Partners fund.

The EY M&A team included: Grzegorz Cywiński, Łukasz Trojanowski, Marcin Skrobek, Maciej Świerkocki and Kamil Homski.

As part of the legal advice, the client was advised by the lawyers from EY Law: Magdalena Kasiarz, Andrzej Laprus and Marta Sadowska.

MED-LUX Sp. z o.o. is a provider of family medicine (GP), occupational medicine, outpatient care by specialist doctors and offers access to extended, specialist diagnostics. The company has 28 specialist clinics operating within two outpatient clinics located in Przeźmierowo and Luboń in the Wielkopolskie Voivodeship, as well as a Rehabilitation Centre (also located in Przeźmierowo).

Scanmed S.A. is a group whose activities include primary health care, outpatient specialist care and hospital treatment in nearly 40 locations throughout Poland, including 13 with coronary care units. The company operates three multi-speciality hospitals – St. Raphael's Hospital in Cracow, Rudolf Weigl Hospital in Blachownia and Ars Medical in Piła. Their activities are complemented by medical centers located in various cities in Poland, including a special offer for the academic community.

Abris Capital Partners is one of the leading private equity firms in the CEE region, which aims to support the most ambitious mid-market companies in their development and achievement of the status of regional champions. Established in 2007 with an investment capital of almost EUR 1.3 billion, Abris has raised funds from many leading global investment institutions, including private and public pension institutions, funds and capital raised by universities.